KCNJ2 inhibition: a therapeutic target for traumatic brain injury
Using cortical organoids, researchers discovered that targeting KCNJ2 could reduce nerve cell death after TBI.
List view / Grid view
Using cortical organoids, researchers discovered that targeting KCNJ2 could reduce nerve cell death after TBI.
New findings show that age-related MC4R+ cilia shortening causes middle-aged obesity and leptin resistance, which could lead to obesity treatment.
Dr Amber Van Laar shares her remarkable journey in STEM. From a childhood fascination with science and medicine to a pivotal role as VP Clinical Development, AskBio. In this interview, she explores the profound impact of her early exposure to neuro-oncology, the challenges faced as a physician-scientist, and the pursuit…
Researchers have identified that AF1q is highly expressed in neuroblastoma, and could be used to destabilise N-Myc.
Researchers discovered that NPTX2 protein accumulated in cells containing abnormal TDP-43 in FTD and ALS patients.
For the first time, researchers reveal the involvement of OXT in object recognition memory through the supramammillary nucleus.
A mechanism by which the immune system influences central nervous system function and behaviour has been discovered.
The discovery of a mechanism involving anxiolytic effects of GH may lead to the development of new classes of anxiolytic drugs.
Researchers found that ANG in its mutated form slows stem cell differentiation, resulting in neurodevelopmental defects in adult nerve cells.
Anthrobots derived from human tracheal cells could perform therapeutic work without initiating an immune response.
A 2D neuromuscular junction model enables high-throughput screening to discover new treatments for neuromuscular diseases.
A new finding that pathological alpha-synuclein causes cells to increase protein synthesis suggests new targets for treating PD.
An AI system could be used to observe how physical constraints shape brains and impact people with cognitive difficulties.
Astrocyte plasticity is correlated with upregulation of the Galectin 3 protein, which may greatly contribute to biomarker discovery.
iPS-cell-derived microglia in brain organoids have enabled scientists to understand early brain development and microglia-associated disease.